New paediatric indications for direct thrombin inhibitors

Details New paediatric indications for direct thrombin inhibitors New paediatric indications for direct thrombin inhibitors

A - Human Necessities

61

K

A61K 45/06 (2006.01)

Patent

CA 2657270

The invention relates to new paediatric indications for direct thrombin inhibitors such as dabigatran etexilate.

L'invention porte sur de nouvelles indications pédiatriques pour des inhibiteurs directs de la thrombine tels que dabigatran etexilate.

Affiliated with

Also associated with

Rating

New paediatric indications for direct thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New paediatric indications for direct thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New paediatric indications for direct thrombin inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1596075